Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Xvivo Perfusion Ab Ord (XVIPF)

Xvivo Perfusion Ab Ord (XVIPF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.92
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.9000 unch
on 06/12/20
16.9000 unch
on 06/12/20
N/A (+68.09%)
since 04/02/20
3-Month
10.0541 +68.09%
on 04/02/20
16.9000 unch
on 06/12/20
+1.3000 (+8.33%)
since 03/03/20

Most Recent Stories

More News
The Global Organ Preservation Market is expected to grow from USD 281.12 Million in 2018 to USD 474.12 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 7.75%

Reportlinker.com announces the release of the report "Global Organ Preservation Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025"...

MDSY : 0.73 (+4.29%)
XVIPF : 16.9000 (+68.09%)
United Therapeutics Announces FDA Approval Of XPS(TM) And Steen Solution(TM) Used To Perform Centralized Ex-Vivo Lung Perfusion Services

United Therapeutics Corporation (Nasdaq: UTHR) today announced that its collaborator, XVIVO Perfusion, Inc., a subsidiary of XVIVO Perfusion AB (STO: XVIVO), has received Premarket Approval (PMA) from...

XVIPF : 16.9000 (+68.09%)
UTHR : 110.52 (+1.26%)
Trade XVIPF with:

Key Turning Points

2nd Resistance Point 16.9000
1st Resistance Point 16.9000
Last Price 16.9000
1st Support Level 16.9000
2nd Support Level 16.9000

See More

52-Week High 16.9000
Last Price 16.9000
Fibonacci 61.8% 14.2849
Fibonacci 50% 13.4770
Fibonacci 38.2% 12.6692
52-Week Low 10.0541

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar